Testicular testosterone produced during a critical perinatal period is thought to masculinize and defeminize the male brain from the inherent feminization program and induce male-typical behaviors in the adult. These actions of testosterone appear to be exerted not through its androgenic activity, but rather through its conversion by brain aromatase into estrogen, with the consequent activation of estrogen receptor (ER)-mediated signaling. Thus, the role of androgen receptor (AR) in perinatal brain masculinization underlying the expression of male-typical behaviors remains unclear because of the conversion of testosterone into estrogen in the brain. Here, we report a null AR mutation in mice generated by the Cre-loxP system. The AR-null mutation in males (AR L؊/Y ) resulted in the ablation of male-typical sexual and aggressive behaviors, whereas female AR-null homozygote (AR L؊/L؊ ) mice exhibited normal female sexual behaviors. Treatment with nonaromatizable androgen (5␣-dihydrotestosterone, DHT) was ineffective in restoring the impaired male sexual behaviors, but it partially rescued impaired male aggressive behaviors in AR L؊/Y mice. Impaired maletypical behaviors in ER␣ ؊/؊ mice were restored on DHT treatment. The role of AR function in brain masculinization at a limited perinatal stage was studied in AR L؊/L؊ mice. Perinatal DHT treatment of females led to adult females sensitive to both 17␤-estradiol and DHT in the induction of male-typical behaviors. However, this female brain masculinization was abolished by AR inactivation. Our results suggested that perinatal brain masculinization requires AR function and that expression of male-typical behaviors in adults is mediated by both AR-dependent and -independent androgen signaling.
I
t is thought that local production of estradiol, converted from testicular testosterone by brain aromatase, and the subsequent activation of estrogen receptor (ER)-mediated signaling is sufficient to induce brain masculinizaton in the male fetus and eventual expression of male typical behaviors in the adult (1) (2) (3) . This hypothesis is supported by findings that mice deficient in either ER or aromatase display severely reduced male-typical behaviors (2) (3) (4) . However, studies have indicated that when androgens are given to the female fetus, male-typical behaviors can be induced on further androgen treatment in adulthood (5, 6) . Thus, although androgen receptor (AR)-mediated androgen actions are thought to be important in the induction of maletypical behaviors, the activity of locally converted estrogen from aromatizable androgens in the brain has prevented the assessment of the role of AR in perinatal brain masculinization and expression of male-typical behaviors.
Naturally occurring mutations in mammalian AR genes, located on the X chromosome and therefore present as a single copy in males, result in AR dysfunction that can lead to androgen-insensitive testicular feminization mutation (Tfm) (7, 8) . Tfm is characterized by a variety of phenotypic abnormalities along with species-specific effects (8) . However, Tfm mice appear to express a truncated AR protein (9) . Most male animals with severe androgen insensitivity exhibit female-like external sexual organs and are infertile (8) . This fact makes it impossible to generate female animals homozygous for AR deficiency and precludes the establishment of AR-null mutant (AR knockout, ARKO) lines either in nature or by conventional gene disruption techniques. Therefore, to define AR function we used the Cre-loxP system to allow the AR-null mutation (10) to be passed to both male and female offspring (11, 12) . We report here that perinatal brain masculinization requires AR function and that expression of male-typical behaviors in adults is mediated by both receptor-dependent and -independent androgen signaling.
Materials and Methods
Generation of ARKO Mice. AR genomic clones were isolated from a TT2 embryonic stem cell genomic library by using human AR A͞B domain cDNA as a probe. The targeting vector consisted of a 7.6-kb 5Ј homologous region containing exon 1, a 1.3-kb 3Ј homologous region, a single loxP site, and the neo cassette with two loxP sites (10) . Two targeted clones (FB-18 and FC-61), identified by Southern analysis using probes A and B (Fig. 1b) , were aggregated with single eight-cell embryos from CD-1 mice. Floxed AR mice (C57BL͞6) were then crossed with the CMVCre transgenic mice. The two lines exhibited the same phenotypic abnormalities. The chromosomal sex of each pup was determined by genomic PCR amplification of the Sry gene on the Y chromosome.
RNA Analysis. Total RNA was isolated by the improved acidguanidine-phenol-chloroform method and poly(A) ϩ RNA purified with Dynabeads (Dynal, Oslo). Total and poly(A) ϩ RNA was separated in formaldehyde-containing agarose gels for Northern blot analysis as described (13, 14) . An AR cDNA fragment (353 bp: 2368-2721) or neuronal nitric oxide synthase (nNOS) cDNA fragment (1,814 kbp: 182-1995) was used as a probe. RT-PCR analysis was conducted as described in Supporting Materials and Methods in Supporting Text, which is published as supporting information on the PNAS web site.
Protein Analysis. To detect AR protein expression (7), brain cell lysates were separated by SDS͞PAGE and transferred onto nitrocellulose membranes. Membranes were probed with poly-clonal AR antibodies (C-19 and N-20; Santa Cruz Biotechnology) and then peroxidase-conjugated second antibody. Blots were visualized by using an ECL detection kit (Amersham Bioscience). Immunohistochemistry was performed as described in Supporting Materials and Methods. (3, 4, 16) . As stimuli, female mice (C57BL͞6J) were ovariectomized and injected with estradiol benzoate (30 g at 48 h and 15 g at 24 h before tests) and progesterone (500 g at 4 h before tests), with only females that showed lordosis in response to mounting by stud males subjected to experimentation. Sexual behaviors of each male were recorded for either 30 or 90 min as follows: number of mounts and intromissive and ejaculatory behaviors. The latency period (seconds) of the first male behavioral response was also measured.
Male Aggressive Behavior Test. Each mouse was tested three times in his home cage (as a resident) against an olfactory bulbectomized male (C57BL͞6J) intruder mouse for 15 min (3, 4) . For each experiment, percent of mice showing aggressive behaviors, total number of aggressive bouts, and latency (seconds) to first aggressive behavioral act by resident males were scored. An aggressive bout was defined as a consecutive series of behavioral acts separated by Ͻ3 sec, consisting of tail rattling, chasing, boxing, biting, offensive attacks, and wrestling.
Female Sexual Behavior Test. Gonadally intact or hormone-primed mice were introduced into a vigorous WT male's home cage (17) . Lordosis in response to mount was defined as receptive posture with dorsoflexion of the back and elevation of the hindquarters. The lordosis quotient was calculated as the number of lordosis events per 10 mounts ϫ 100. Observation continued for 20 min after introduction of the experimental animals, or until they received 10 mounts.
Perinatal DHT Treatment. Pregnant mice were implanted with 21-day time-release pellets (Innovative Research of America) containing DHT (35 mg per pellet) from days 14 to 19 of pregnancy. All offspring were injected with DHT (300 g͞30 l) on days 0, 2, 4, 6, and 8 after birth. PLA and sesame oil were administered to control animals in the same schedule. These AR LϪ/LϪ and male and female WT mice were gonadectomized at 50 days of age, and behavioral tests were performed after hormone treatments as described above.
Statistical Analysis. Behavioral test data are shown as mean (ϮSE) and analyzed by using Student's t test or two-way ANOVA followed by post hoc comparison with the Fisher's protected least significant difference test. The nonparametric KruskalWallis test and Mann-Whitney U test were used when variances were not equal among groups. Differences in incidences of behaviors were analyzed by the 2 test or Fisher's exact probability test.
Results

Generation of AR-Deficient
Mice by Using the Cre-loxP System. To circumvent male infertility due to AR inactivation, we introduced three loxP sites around exon 1, which encodes the transcription start site (Fig. 1a) , to generate AR-floxed (flox͞Y) mice (Fig. 1b) . AR-floxed male (AR L3/Y ) and female (AR L3/ϩ ) mice exhibited no overt abnormalities in terms of sexual behaviors, with normal reproduction frequencies and AR mRNA expression levels ( (Fig. 1d) . No AR transcripts in the brain were detected by Northern blotting (Fig. 1e) , and RT-PCR using primer pairs designed to amplify exons encoding the AR ORF also failed to detect AR mRNA (data not shown). Immunoblotting experiments using Nand C-terminal antibodies for AR showed no AR protein expression in the brain and confirmed the inactivation of the AR gene (Fig. 1f ) . mice exhibited femaletypical external appearance, including a vagina with a blind end, and a clitoral-like phallus instead of a penis and scrotum (Fig.  1g) , similar to that observed in another mice line (18) . Male reproductive organs, including seminal vesicles, vas deferens, epididymis, and prostate, were absent in AR LϪ/Y mice (Fig. 1g) . Although no ovaries or uteri were observed, small inguinal testes were present. Histological examination of these testes showed that spermatogenesis was severely arrested (Fig. 5a ). Testicular androgen levels were very low [testosterone, t(24) ϭ 3.1, P Ͻ 0.01; and DHT, t(15) ϭ 3.1, P Ͻ 0.01], whereas serum estrogen levels appeared normal in 10-week-old mutant mice (Fig. 5b) . To our surprise, no phenotypic abnormalities in female reproductive organs were found in female AR LϪ/LϪ mice up to 10 weeks of age (H. Shiina, J. Miyamoto, T. Sato, T. Matsumoto, and S. Kato, unpublished results). (Fig. 5b) and normal levels of ER ␣ and ␤ protein expression in the hypothalamus (Fig. 2g) . To restore the reduced serum androgen levels, gonadectomized AR LϪ/Y mice were given nonaromatizable androgen DHT. Although DHT treatment of WT male littermates enhanced the manifestation of male sexual Fig. 2 b-d] . Our results suggested that both ARindependent and -dependent pathways mediated the effects of DHT on male aggressive behaviors.
In agreement with previous findings (2, 19), E 2 also potently induced male sexual behaviors in WT male mice [ 2 (1) ϭ 10.5, P Ͻ 0.01], whereas E 2 -treated AR LϪ/Y mice showed recovery of mounts and intromissions [ 2 (1) ϭ 5.2, P Ͻ 0.05] but not ejaculation. However, where behavioral recovery did occur, it was only to Ϸ50% of that observed in WT mice (Fig. 2a) . The impaired aggressive behaviors of male ARKO mice were effectively restored by E 2 treatment [ 2 (1) ϭ 7.9, P Ͻ 0.01; Fig. 2 b-d] .
Absence of Female-Typical Behaviors in Male ARKO Mice. We then tested the female sexual behaviors of gonadally intact AR LϪ/Y mice by placing these mice into the home cages of WT males (17) . AR LϪ/Y mice did not perform lordosis in response to WT male mounts (Fig. 2e) . To further verify the inability of AR LϪ/Y mice to display lordosis, ovarian hormones were administered to stimulate female sexual behaviors. In WT females, the levels of lordosis gradually increased after administration of E 2 , whereas no lordosis was induced in AR LϪ/Y mice even when progesterone was given together with E 2 (Fig. 2 e and f ) . In contrast, female intact AR LϪ/LϪ mice exhibited normal levels of lordosis, similar to that of WT females (Fig. 2e) , and fertility (data not shown) but not male-typical behaviors. (Fig. 3a) . Similarly, the impaired aggressive behaviors of male ER␣ Ϫ/Ϫ mice were partially recovered by DHT treatment as measured by increased incidences of aggression [ 2 (1) ϭ 6.2, P Ͻ 0.05] with shorter latencies (F 3,26 ϭ 5.41, P Ͻ 0.05; Fig. 3 b-d) . Thus, male behavioral responses to DHT in null ER␣ Ϫ/Ϫ mice further confirmed the physiological importance of androgen signaling in male-typical behaviors.
Partial Recovery of Impaired Male-Typical Behaviors in ER␣
DHT-Induced Perinatal Brain Masculinization in Female Mice Was
Abolished by AR Inactivation. Serum levels of testosterone in newborn AR LϪ/Y mice were still within the normal range compared with WT males (WT, 618.8 Ϯ 233.1 pg͞ml; and ARKO, 404.9 Ϯ 171.7 pg͞ml; Fig. 4f ). However, we could not exclude the possibility that the lowered estrogen conversion due to impaired testosterone production from atrophic testis was insufficient to cause masculinization of the AR LϪ/Y fetal brain. Therefore, to precisely define the role of AR function in brain masculinization, we assessed AR-mediated androgen activity in the female fetus. Intact female brains physiologically undergo the innate feminization program due to the absence of sex hormone activity. It is well known that perinatal exposure of female rodents to androgens results in behavioral masculinization, observed as increased male-typical behavioral patterns after ovariectomy and further hormonal treatment in adulthood (5, 21) . Only 30-33% of control WT females showed mount and intromissive patterns, but not ejaculatory patterns, even after either DHT or E 2 were administered in adulthood (Fig. 4a) . In contrast, perinatal DHT treatment (see Fig. 6 , which is published as supporting information on the PNAS web site) induced mount and intromissive patterns in WT females on further postpubertural DHT [mount and intromissions, 2 (1) ϭ 9.7, P Ͻ 0.01] or E 2 [mount and intromissions, 2 (1) ϭ 10.5, P Ͻ 0.05] treatment (Fig. 4a) . Perinatal DHT exposure enabled 2 of 10 WT females to exhibit ejaculatory patterns in response to postpubertural DHT treatment. Similarly, male aggressive behaviors were also induced in WT females exposed perinatally to DHT after either DHT [2(1) ϭ 6.5, P Ͻ 0.05] or E 2 [2(1) ϭ 9.8, P Ͻ 0.01] treatment in adulthood (Fig. 4 b-d) . However, such male-typical patterns were completely abolished in female ARKO (AR LϪ/LϪ ) mice. Similar to control WT females, AR LϪ/LϪ mice exposed to perinatal DHT treatments exhibited normal female sexual behaviors in response to E 2 and progesterone (Fig. 4e) . Thus, it is likely that full and normal brain masculinization and defeminization require both androgen and estrogen signaling.
Alteration in Gene Expression of Neuronal Nitric Oxide Synthase by AR
Inactivation. Finally, to gain insight into the molecular basis of impaired male-typical behaviors in male ARKO mice, we analyzed the expression of several genes known to be involved in the control of male-typical behaviors (as described in Supporting Results in Supporting Text). No significant alterations in neuropeptide (oxytocin, vasopressin, and calcitonin gene-related peptide) and monoaminergic-specific gene [tyrosine hydroxylase, tryptophan hydroxylase, and 5-hydroxytryptamine (5-HT) receptor 5-HT1A and 5-HT1B] mRNA levels were detected by semiquantitative RT-PCR analysis of AR LϪ/Y mouse hypothalamus (Fig. 7 a-g , which is published as supporting information on the PNAS web site). In contrast, a clear reduction in nNOS mRNA expression in the hypothalamus of AR LϪ/Y mice was observed by Northern blotting and semiquantitative RT-PCR (Fig. 4g) . Thus, our results suggested the possible involvement of NO neurotransmission in male-typical behaviors regulated by AR.
Discussion
The present study revealed that AR gene inactivation in intact male mice caused the complete loss of male sexual behaviors and severely reduced male aggressive behaviors. Furthermore, AR LϪ/Y mice displayed significantly reduced male-typical behaviors regardless of sex steroid hormone treatment. Thus, these results confirmed that AR function is critical for male-typical behaviors. Nevertheless, it was still impossible to determine whether impaired male-typical behavior in AR LϪ/Y mice was due to the lack of AR function in adulthood or the failure of masculinization because of AR deficiency during the perinatal stage.
To address this issue, we used female AR-null mutant mice and found that DHT-induced brain masculinization at the perinatal stage was abolished in AR LϪ/LϪ mice. These data provide genetic evidence that liganded-AR function alone is sufficient for the sexual conversion of perinatal female brains. Moreover, as both E 2 -and DHT-induced male-typical behaviors in adult WT females treated perinatally with DHT, it is likely that once the brain is perinatally masculinized through activated AR function, the sexually developed brain becomes sensitive to both androgens and estrogens with regard to the expression of male-typical behaviors in adulthood. Thus, our results revealed that both brain masculinization during a limited perinatal period and expression of male-typical behaviors in adults require ARmediated androgen signaling. Furthermore, the finding of significantly reduced nNOS mRNA levels after AR inactivation suggested that the nNOS gene may be one of the genes downstream of AR-mediated androgen signaling. Male sexual behaviors were abolished in intact male ARKO mice, whereas treatment with E 2 , but not DHT, rescued male sexual behaviors without the induction of female sexual behaviors. This finding indicated that the brains of AR LϪ/Y mice were defeminized and partially masculinized. However, human patients with severe Tfm are usually socially adopted as females, irrespective of castration and E 2 treatments. Together with the findings that prenatal treatment of female rhesus monkeys with DHT had clear and significant defeminizing and masculinizing effects on behavior (22) , it appears that AR may serve a more critical role in male-typical behaviors than ER in higher mammals, including humans. Alternatively, because human sexuality is a complex behavioral trait formed through the combined function of multiple factors, the influence of social learning in humans might generate a species difference in terms of AR function in male sexual behaviors.
Examination of hormonal responses in AR LϪ/Y and ER␣ Ϫ/Ϫ mice suggested that androgen and estrogen receptor functions are convergent with regard to male sexual behaviors. However, as ejaculation was not restored in single-receptor knockout mice by any of the hormone treatments, both AR and ER function appears to be essential for normal male sexual behaviors. Along with mapping the sites of receptor activity in the brain and identification of target genes, evaluation of the critical developmental stages for AR function and its downstream factors is of particular interest and will be greatly assisted by the spatiotemporal control of receptor gene inactivation (10) .
Unlike male-typical behaviors, the expression of female sexual behaviors was unaffected by AR inactivation. Furthermore, perinatal DHT exposure had no effect on female sexual behaviors in AR LϪ/LϪ or WT female mice, and no female sexual behaviors were induced in AR LϪ/Y mice in response to any hormone treatment. These findings suggested that the defeminization process is totally independent from masculinization in the brains of both sexes and that the function of liganded ER, but not AR, appears to be indispensable for brain defeminization.
In contrast to male sexual behaviors, male aggressive behaviors appeared to be mediated at least in part by AR-independent signaling and were distinct from ER-mediated estrogen signaling. Although the molecular basis for this receptor-independent DHT action in males is unclear at present, DHT may exert its effects through an as-yet-unknown cell-membrane receptor (23) . This hypothesis is supported by recent reports of the identification of cell membrane receptors for progesterone (24) . Another possibility is that a currently unidentified DHT metabolite may be responsible for activating a nuclear receptor (25, 26) involved in male aggressive behaviors. Thus, AR-null mutant mice will be useful in further investigating novel androgen-signaling pathways that are independent of AR.
